Barclays »

Mural Oncology shares owned by Barclays

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $167k 28k 5.94

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Mural Oncology

Westfield Capital Management Company
BlackRock
Vanguard Group
Newtyn Management
PRIMECAP Management Company
Citadel Advisors
Squarepoint Ops
Millennium Management
Hrt Financial
Artisan Partners Limited Partnership
Norges Bank Investment Management
Goldman Sachs Group
Nicollet Investment Management
Centiva Capital
Susquehanna International

View all funds holding Mural Oncology